Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma.
Saved in:
| Title: | Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma. |
|---|---|
| Authors: | Christopeit M; Department of Medicine IV, Oncology/Hematology, University Hospital Halle Saale, Halle Saale, Germany., Lenz G, Forstpointner R, Bartelheim K, Kühnbach R, Naujoks K, Schalhorn A |
| Source: | Chemotherapy [Chemotherapy] 2008; Vol. 54 (4), pp. 309-14. Date of Electronic Publication: 2008 Aug 14. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 0144731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9794 (Electronic) Linking ISSN: 00093157 NLM ISO Abbreviation: Chemotherapy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
